Metoprolol Medical Valley

Metoprolol Tartrate, the active ingredient in Metoprolol Medical Valley, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, relieve angina, improve outcomes after myocardial infarction, and treat certain cardiac rhythm disorders.

GNH USA supplies Metoprolol Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier, originating from the European Union, and serves hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Metoprolol Tartrate is a selective β1‑adrenergic antagonist used in cardiovascular disease management. - Hypertension: lowers systolic and diastolic pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival by limiting cardiac workload after an attack. - Heart failure: reduces ventricular remodeling and symptoms of reduced ejection fraction. - Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other rhythm disturbances.

Metoprolol Tartrate may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe bradycardia: heart rate dropping to dangerously low levels. - Heart block: impaired electrical conduction requiring medical attention. - Bronchospasm: worsening of asthma or chronic obstructive pulmonary disease. - Hypotension: significant drop in blood pressure leading to fainting. - Depression or mood changes: rare but reported psychological effects.

Before initiating therapy, consider the following precautions. - Cardiovascular assessment: evaluate heart rate, blood pressure, and cardiac function. - Respiratory disease: avoid in patients with uncontrolled asthma or severe COPD. - Diabetes monitoring: may mask hypoglycaemia symptoms; adjust glucose checks. - Concomitant drugs: review other beta‑blockers or calcium channel blockers for additive effects. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Metoprolol Tartrate can interact with several medicines.

Major Interactions (Avoid): - Non‑selective beta‑blockers: combined use may cause excessive bradycardia. - Calcium channel blockers (verapamil, diltiazem): increase risk of heart block and hypotension.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: may enhance hypoglycaemia; monitor glucose levels. - Antidepressants (SSRIs, SNRIs): may increase plasma metoprolol concentrations. - NSAIDs: can attenuate antihypertensive effect; watch blood pressure response.